1. Home
  2. PAYC vs CYTK Comparison

PAYC vs CYTK Comparison

Compare PAYC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

HOLD

Current Price

$127.23

Market Cap

8.9B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.09

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYC
CYTK
Founded
1998
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
7.6B
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
PAYC
CYTK
Price
$127.23
$61.09
Analyst Decision
Buy
Strong Buy
Analyst Count
15
18
Target Price
$170.71
$88.50
AVG Volume (30 Days)
1.7M
1.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.20%
N/A
EPS Growth
N/A
N/A
EPS
8.08
N/A
Revenue
$433,047,000.00
$13,368,000.00
Revenue This Year
$8.79
$8.73
Revenue Next Year
$7.39
$309.93
P/E Ratio
$15.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$104.90
$29.31
52 Week High
$267.76
$70.98

Technical Indicators

Market Signals
Indicator
PAYC
CYTK
Relative Strength Index (RSI) 46.89 45.28
Support Level $112.93 $59.13
Resistance Level $138.86 $65.72
Average True Range (ATR) 4.46 2.61
MACD 0.03 0.01
Stochastic Oscillator 31.44 46.24

Price Performance

Historical Comparison
PAYC
CYTK

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: